These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17036307)

  • 41. Using Administrative Data to Ascertain True Cases of Muscular Dystrophy: Rare Disease Surveillance.
    Smith MG; Royer J; Mann JR; McDermott S
    JMIR Public Health Surveill; 2017 Jan; 3(1):e2. PubMed ID: 28082256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Duchenne muscular dystrophy with autism spectrum disorder.
    Wu JY; Kuban KC; Allred E; Shapiro F; Darras BT
    J Child Neurol; 2005 Oct; 20(10):790-5. PubMed ID: 16417872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fetal alcohol syndrome--Alaska, Arizona, Colorado, and New York, 1995-1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 May; 51(20):433-5. PubMed ID: 12056499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy.
    Ihmsen H; Schmidt J; Schwilden H; Schmitt HJ; Muenster T
    Anesthesiology; 2009 May; 110(5):1016-9. PubMed ID: 19352159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Parental perspectives on the diagnostic process for Duchenne and Becker muscular dystrophy.
    Daack-Hirsch S; Holtzer C; Cunniff C
    Am J Med Genet A; 2013 Apr; 161A(4):687-95. PubMed ID: 23494880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Illness-associated muscle weakness in dystroglycanopathies.
    Carlson CR; McGaughey SD; Eskuri JM; Stephan CM; Zimmerman MB; Mathews KD
    Neurology; 2017 Dec; 89(23):2374-2380. PubMed ID: 29101272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enigmatic conflict of clinical and molecular diagnosis in Duchenne/Becker muscular dystrophy.
    Dubowitz V
    Neuromuscul Disord; 2006 Dec; 16(12):865-6. PubMed ID: 17118656
    [No Abstract]   [Full Text] [Related]  

  • 48. Mothers' psychological adaptation to Duchenne/Becker muscular dystrophy.
    Peay HL; Meiser B; Kinnett K; Furlong P; Porter K; Tibben A
    Eur J Hum Genet; 2016 May; 24(5):633-7. PubMed ID: 26306645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Valley sign in Becker muscular dystrophy and outliers of Duchenne and Becker muscular dystrophy.
    Pradhan S
    Neurol India; 2004 Jun; 52(2):203-5. PubMed ID: 15269471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Duchenne muscular dystrophy: issues in expanding newborn screening.
    Kemper AR; Wake MA
    Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Capture-recapture methodology to study rare conditions using surveillance data for fragile X syndrome and muscular dystrophy.
    Smith MG; Royer J; Mann J; McDermott S; Valdez R
    Orphanet J Rare Dis; 2017 Apr; 12(1):76. PubMed ID: 28427448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Duchenne/Becker muscular dystrophy in the family: have potential carriers been tested at a molecular level?
    Helderman-van den Enden AT; van den Bergen JC; Breuning MH; Verschuuren JJ; Tibben A; Bakker E; Ginjaar HB
    Clin Genet; 2011 Mar; 79(3):236-42. PubMed ID: 21070212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of cardiomyopathy in Duchenne and Becker's muscular dystrophy.
    Sultan A; Fayaz M
    J Ayub Med Coll Abbottabad; 2008; 20(2):7-13. PubMed ID: 19385447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Phenotypic heterogeneity and phenotype-genotype correlations in dystrophinopathies: Contribution of genetic and clinical databases].
    Humbertclaude V; Hamroun D; Picot MC; Bezzou K; Bérard C; Boespflug-Tanguy O; Bommelaer C; Campana-Salort E; Cances C; Chabrol B; Commare MC; Cuisset JM; de Lattre C; Desnuelle C; Echenne B; Halbert C; Jonquet O; Labarre-Vila A; N'guyen-Morel MA; Pages M; Pepin JL; Petitjean T; Pouget J; Ollagnon-Roman E; Richelme C; Rivier F; Sacconi S; Tiffreau V; Vuillerot C; Béroud C; Tuffery-Giraud S; Claustres M
    Rev Neurol (Paris); 2013; 169(8-9):583-94. PubMed ID: 23954141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evolution of gastric electrical features and gastric emptying in children with Duchenne and Becker muscular dystrophy.
    Borrelli O; Salvia G; Mancini V; Santoro L; Tagliente F; Romeo EF; Cucchiara S
    Am J Gastroenterol; 2005 Mar; 100(3):695-702. PubMed ID: 15743370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Duchenne muscular dystrophy: a 30-year population-based incidence study.
    Dooley J; Gordon KE; Dodds L; MacSween J
    Clin Pediatr (Phila); 2010 Feb; 49(2):177-9. PubMed ID: 20080524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anesthesia and Duchenne or Becker muscular dystrophy: review of 117 anesthetic exposures.
    Segura LG; Lorenz JD; Weingarten TN; Scavonetto F; Bojanić K; Selcen D; Sprung J
    Paediatr Anaesth; 2013 Sep; 23(9):855-64. PubMed ID: 23919455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors Associated With Health-Related Quality of Life in Children With Duchenne Muscular Dystrophy.
    Wei Y; Speechley KN; Zou G; Campbell C
    J Child Neurol; 2016 Jun; 31(7):879-86. PubMed ID: 26863997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive--compulsive disorder.
    Hendriksen JG; Vles JS
    J Child Neurol; 2008 May; 23(5):477-81. PubMed ID: 18354150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral health considerations in muscular dystrophies.
    Balasubramaniam R; Sollecito TP; Stoopler ET
    Spec Care Dentist; 2008; 28(6):243-53. PubMed ID: 19068065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.